Streetbeat News

Revenues

WS

Worthington Steel reported Q1 earnings of $0.56 per share, missing the $0.60 estimate, but sales of $834M beat the $757.1M estimate. Earnings decreased by 55.56% from last year, while sales decreased by 7.93%.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:11 pm

DIS

Goldman Sachs analyst Michael Ng maintains a Buy rating on Disney, citing strong box office and streaming growth as potential offsets to weaknesses in Experiences and linear segments. Ng forecasts Disney's Q4 earnings to exceed consensus estimates, driven by subscriber growth and price increases in streaming.

Portfolio Pulse from Chris Katje

September 25, 2024 | 8:09 pm

CNXC

Concentrix projects its Q4 revenue to be between $2.42 billion and $2.47 billion, with an adjusted EPS of $2.90 to $3.16. For the fiscal year 2024, the company expects revenue between $9.591 billion and $9.641 billion, and an adjusted EPS of $11.05 to $11.31.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:08 pm

CNXC

Concentrix reported Q3 2024 earnings with an adjusted EPS of $2.87, missing the estimate of $2.93, but sales of $2.387 billion beat the estimate of $2.382 billion. Sales increased by 46.20% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:06 pm

MU

Micron Technology has projected its Q1 revenue to be approximately $8.70 billion, with a margin of $200 million. The adjusted earnings per share (EPS) is expected to range between $1.66 and $1.82.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 8:04 pm

MLM

Martin Marietta Materials (NYSE:MLM) has outperformed the market over the past decade with an average annual return of 15.33%, resulting in a $100 investment growing to $413.96. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:00 pm

FI

Fiserv (NYSE:FI) has significantly outperformed the market over the past decade, with an annualized return of 18.49%. A $100 investment in Fiserv 10 years ago would now be worth $546.73, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:00 pm

ASND

BMRN

BioMarin Pharmaceutical Inc. remains confident in its 2027 revenue target despite competition from Ascendis Pharma. Goldman Sachs maintains a Buy rating on BioMarin, highlighting potential growth from Voxzogo and external business development. BioMarin is implementing a cost transformation program to achieve its financial goals.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 7:50 pm

AME

AMETEK Inc. (NYSE:AME) is trading at $171.16 with a 0.36% increase. Its P/E ratio of 29.71 is lower than the Electrical Equipment industry's average of 39.68, suggesting potential undervaluation or weaker growth prospects. Investors should consider multiple metrics for a comprehensive analysis.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 7:30 pm

MANH

Manhattan Associates (NASDAQ:MANH) has significantly outperformed the market over the past 15 years, with an annualized return of 30.89%. A $100 investment in MANH 15 years ago would now be worth $5,582.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 7:30 pm